134 related articles for article (PubMed ID: 31966897)
1. Expression of STING and MIF in tumor infiltration lymphocytes as prognostic factors in patients with ESCC.
Wang ZC; Zhang L; Li ZL; He J; Cai TT; Yang DJ; Xie DR
Int J Clin Exp Pathol; 2017; 10(9):10066-10074. PubMed ID: 31966897
[TBL] [Abstract][Full Text] [Related]
2. The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma.
Zhang L; Ye SB; Ma G; Tang XF; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
J Transl Med; 2013 Mar; 11():60. PubMed ID: 23497377
[TBL] [Abstract][Full Text] [Related]
3. Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.
Zhang L; Ye SB; Li ZL; Ma G; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
Int J Clin Exp Pathol; 2014; 7(7):3887-97. PubMed ID: 25120765
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
[TBL] [Abstract][Full Text] [Related]
5. CD103
Chu Y; Liao J; Li J; Wang Y; Yu X; Wang J; Xu X; Xu L; Zheng L; Xu J; Li L
J Cancer; 2019; 10(21):5234-5243. PubMed ID: 31602274
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: An Updated Meta-Analysis.
Hao J; Li M; Zhang T; Yu H; Liu Y; Xue Y; An R; Wang S
Front Oncol; 2020; 10():614. PubMed ID: 32411602
[No Abstract] [Full Text] [Related]
7. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
8. Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma.
Zhao JJ; Zhou ZQ; Wang P; Chen CL; Liu Y; Pan QZ; Zhu Q; Tang Y; Weng DS; Xia JC
Cancer Manag Res; 2018; 10():6457-6468. PubMed ID: 30568505
[TBL] [Abstract][Full Text] [Related]
9. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Lymphocyte Activation Gene-3 (LAG-3) Expression in Esophageal Squamous Cell Carcinoma.
Zhang Y; Liu YD; Luo YL; Liu BL; Huang QT; Wang F; Zhong Q
J Cancer; 2018; 9(22):4287-4293. PubMed ID: 30519331
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumor PD-L1 expression combined with CD8
Wang Q; Lou W; Di W; Wu X
Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
Ren Y; Law S; Huang X; Lee PY; Bacher M; Srivastava G; Wong J
Ann Surg; 2005 Jul; 242(1):55-63. PubMed ID: 15973102
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of interferon regulating factor 4 in esophageal squamous cell carcinoma.
Sun R; Ye L; Zhang M; Qiu Z; Xiang T; Tang J; Wang X; Li L; Luo J; Zhang D; Ren G
Biochem Biophys Res Commun; 2018 Nov; 506(3):685-691. PubMed ID: 30376993
[TBL] [Abstract][Full Text] [Related]
18. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
[TBL] [Abstract][Full Text] [Related]
19. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H
Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798
[TBL] [Abstract][Full Text] [Related]
20. The correlation of BER protein, IRF3 with CD8+ T cell and their prognostic significance in upper tract urothelial carcinoma.
Wang LA; Yang B; Rao W; Xiao H; Wang D; Jiang J
Onco Targets Ther; 2019; 12():7725-7735. PubMed ID: 31576137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
